跳至主要内容
临床试验/EUCTR2006-001837-16-IT
EUCTR2006-001837-16-IT进行中(未招募)不适用

PRULIFLOXACIN VERSUS LEVOFLOXACIN IN PATIENTS WITH ACUTE BACTERIAL RHINOSINUSITIS ABRS - ND

ANGELINI0 个研究点目标入组 284 人开始时间: 2006年6月23日最近更新:

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
284

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • MALE OR FEMALE ADULTS WITH NO LIMITATION OF RACE; ABRS DEFINED AS A VIRAL UPPER RESPIRATORY TRACT INFECTION CHARACTERIZED BY INCREASE OF SYMPTOMS AFTER 5 DAYS, OR PERSISTENT SYMPTOMS FOR 10 DAYS BEFORE THE SCREENING VISIT, WITH LESS THAN 12 WEEKS DURATION; CLINICAL DIAGNOSIS OF ABRS CHARACTERIZED BY THE PRESENCE OF TWO OR MORE OF NASAL BLOCKAGE/CONGESTION, DISCHARGE ANTERIOR/POST NASAL DRIP, FACIAL PAIN/PRESSURE, REDUCTION/LOSS OF SMELL; CLINICAL DIAGNOSIS OF MODERATE/SEVERE ABRS; WRITTEN INFORMED CONSENT
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • HYPERSENSITIVITY OR ALLERGY TO FLUOROQUINOLONE ANTIBACTERIALS AND/OR TO ANY COMPONENT, NOSOCOMIAL SINUS INFECTION OR INFECTIONS FOLLOWING OR ASSOCIATED WITH NASO-TRACHEAL INTUBATION, CHRONIC OR COMPLICATED RHINOSINUSITIS, NASAL POLYPS, HISTORY OF SINUS SURGERY.

研究者

发起方
ANGELINI

相似试验